SHPH Shuttle Pharmaceuticals Holdings, Inc.
Pharmaceutical Preparations · Nasdaq · SEC CIK 1757499 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY15.5%
TTM EPS YoY158.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-90.1%
ROA-72.5%
ROIC (approx.)-99.2%
Asset turnover—
Leverage & solvency
Liabilities / assets15.9%
Debt / equity0.00x
Current ratio0.11x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.64x
Accruals ratio-26.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | $4.05M | $3.62M |
| SG&A expense | $5.67M | $1.39M |
| Operating income | -$11.92M | -$7.70M |
| Pretax income | $11.43M | $9.14M |
| Net income | -$11.72M | -$9.14M |
| EBITDA | -$11.63M | -$7.69M |
| EPS (basic) | -7.16 | -79.65 |
| EPS (diluted) | -7.16 | -82.60 |
| Weighted avg. shares (diluted) | 1.64M | 115,493 |
| Banking | ||
| Net interest income | — | $100,000 |
| Balance sheet | ||
| Cash & equivalents | $334,005 | $1.92M |
| Current assets | $502,911 | $2.21M |
| PP&E, net | $17,319 | $19,364 |
| Intangibles | $9.84M | — |
| Total assets | $10.48M | $2.51M |
| Current liabilities | $7.97M | $1.53M |
| Total liabilities | $8.22M | $1.80M |
| Shareholders' equity | $2.25M | $709,152 |
| Shares outstanding | 202,362 | 163,093 |
| Cash flow statement | ||
| Operating cash flow | -$9.48M | -$7.33M |
| Investing cash flow | -$3.06M | $2.92M |
| Financing cash flow | $10.95M | $3.76M |
| Depreciation & amortization | $290,107 | $5,463 |
| Stock-based compensation | $932,967 | $259,744 |
Free plan shows the latest 2 periods; Pro shows all 5 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.